Cleared Traditional

K193591 - ARC 400

K193591 is an FDA 510(k) clearance for ARC 400, manufactured by Bowa-Electronics GmbH & Co. KG. The device is a Class 2 General & Plastic Surgery device with product code GEI cleared through the Traditional 510(k) pathway after a 101-day FDA review.

K193591 · Bowa-Electronics GmbH & Co. KG · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2020
Decision
101d
Days
Class 2
Risk

K193591 is an FDA 510(k) clearance for the ARC 400. Classified as Electrosurgical, Cutting & Coagulation & Accessories within the GEI classification (a category for electrosurgical cutting and coagulation devices), Class II - Special Controls.

Submitted by Bowa-Electronics GmbH & Co. KG (Gomaringen, DE). The FDA issued a Cleared decision on April 2, 2020 after a review of 101 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4400 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Bowa-Electronics GmbH & Co. KG devices

FDA 510(k) Submission Details - K193591

510(k) Number K193591 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 2019
Decision Date April 02, 2020
Days to Decision 101 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
14d faster than avg
Panel avg: 115d · This submission: 101d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GEI Device Classification - Class 2, Special Controls

Product Code GEI Electrosurgical, Cutting & Coagulation & Accessories
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4400
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Emergo Global Consulting, LLC
Roxana Cernescu

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GEI Electrosurgical, Cutting & Coagulation & Accessories

All 1257
Devices cleared under the same product code (GEI) and FDA review panel - the closest regulatory comparables to K193591.
CarpX
K200559 · Pavmed, Inc. · Apr 2020
VivAer Stylus
K200300 · Aerin Medical, Inc. · Apr 2020
Voyant Maryland Fusion Device
K200598 · Applied Medical Resources Corp. · Apr 2020
Venus VivaTM
K191065 · Venus Concept USA, Inc. · Apr 2020
Trigger Switch and Cord
K200455 · New Deantronics Taiwan , Ltd. · Mar 2020
Ethicon Megadyne Electrosurgical Generator, Bipolar Footswitch
K193145 · Megadyne Medical Products, Inc. · Mar 2020